---

• n  inability to coordinate voluntary muscle movements; unsteady movements and staggering gait

• The first product of this research was AtaXia (2004), named after the disabling physical condition.
• Within a few years, a newly recognized genetic disorder called FXTAS (fragile X--associated tremor, ataxia syndrome) was part of the literature, though the illness is still often .
• The aphasia and apraxia disappeared after several weeks but the ataxia and reduction of vision persisted for more than six months.

• ataxy
• dyssynergia
• motor ataxia

News & Articles

---

• Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7; first in vivo study of the treatment ...
  The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms. Researchers believe that their results show that a clinical trial in humans is merited.
  June 10, 2013 - Science Daily
• Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7
  The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms. Researchers in France and the US believe that their results show that a clinical trial in humans is merited.
  June 9, 2013 - EurekAlert!
• Accelerated Search Identifies Drug Targets for Neurodegenerative Disease
  Like Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease, spinocerebellar ataxia type 1 (SCA1) is a devastating neurodegenerative disease caused when a toxic protein accumulates inside nerve cells, clogging normal function.
  June 5, 2013 - Howard Hughes Medical Institute